Voice 1: This is Physician in the Loop, the daily briefing on AI in medicine. It's Saturday, November 14th, 2026.
Voice 1: After 26 years, the United States has lost its measles elimination status, outlets reported Friday, citing a commission that reports to the Pan American Health Organization.
Voice 2: That's a follow-up on the review you flagged last week. What actually sealed the finding?
Voice 1: A confidential CDC report to the commission found one strain had spread person to person for a full 12 months, a source told Reuters. The CDC's public count stands at 5,182 confirmed cases this year as of November 5th, across 47 jurisdictions, 96% of them outbreak-associated.
Voice 2: And the deaths? Has that number moved?
Voice 1: The CDC lists six confirmed deaths, but state reports put the number at 10 or more. CDC Director Dr. Erica Schwartz told Reuters, before the decision, that losing the status would be, quote, “the same exact thing” for the agency's work with states on immunization.
Voice 2: What does the country actually have to do to get the status back?
Voice 1: End the transmission, then go a full year without an outbreak.
Voice 2: Millions of Medicaid enrollees who might fail a different kind of federal test just got some breathing room, sort of. CMS told states Thursday they can hold off on cutting anyone off until June 30th, 2027.
Voice 1: Hold off on what, exactly? The requirement still starts January 1st, doesn't it?
Voice 2: It does. States just get to pause denying or ending coverage for people who haven't shown they meet the work requirement, through that June date. They still have to check every application and renewal against it during the pause, and once it ends, noncompliance means losing coverage.
Voice 1: What actually counts as meeting it?
Voice 2: Eighty hours a month of work, community service, a work program or education, for enrollees 19 to 64, or hitting a set income threshold instead. The grace period only covers that piece, not other eligibility rules like income, and a state has to request it in a mitigation plan CMS approves.
Voice 1: Does CMS sound confident this is going smoothly?
Voice 2: The agency's framing it as progress. Dan Brillman, who runs CMS's Medicaid and CHIP center, said, quote, “States have made real progress.”
Voice 1: A hospital system laid out its own bar for AI vendors this week, and it has nothing to do with a federal deadline.
Voice 2: What's the bar?
Voice 1: A 3-to-1 or 5-to-1 return before Houston Methodist will adopt anything, according to Chief Innovation Officer Roberta Schwartz. And they ask every vendor directly how many full-time staff its tool has actually eliminated, not just hours it claims to save.
Voice 2: So a vendor that only saves time doesn't cut it anymore?
Voice 1: Doesn't meet the bar, she said. Operating room scheduling and ambient scribing each carry their own performance measures to keep their funding at the eight-hospital system. Her quote was blunt: “We aren't going to be able to pay for the innovations and keep all the people.”
Voice 2: Did she name anything they've actually dropped for falling short?
Voice 1: No. Nothing named as cut or expanded.
Voice 2: That's a pretty different definition of success than the usual vendor pitch about saved minutes.
Voice 1: A different kind of pause hit a brain implant company this week too.
Voice 2: Synchron stopped clinical trials of its second-generation wireless brain-computer interface, and it's cutting jobs in New York City at the same time.
Voice 1: Is that a safety problem?
Voice 2: Company leaders say no. But WIRED reported the pause followed performance issues, and Synchron is already working on a new device.
Voice 1: What's this device actually supposed to do for patients?
Voice 2: Let people with paralysis, including from ALS, control digital devices. Their first-generation device threads a stent near the motor cortex through a vein with a catheter. CEO Tom Oxley said on a panel the week before, quote, “There are hundreds of components in our system, and it just takes a delayed one to slow down your submission to the FDA.”
Voice 1: A delayed part holding up a whole submission is a strange thing to picture alongside jobs already being cut.
Voice 2: Before we go, something to watch.
Voice 1: What's on it?
Voice 2: Comments close today on proposals from two Medicare contractors, Palmetto and Noridian, to stop covering AI brain MRI quantification software. Both found it not reasonable and necessary.
Voice 1: If both drop coverage, does that end the tool everywhere?
Voice 2: The sources don't say that. It's a coverage call from those two contractors, not a nationwide ruling.
Voice 1: Worth watching whether other contractors follow. What else is new?
Voice 2: HLTH 2026 opens tomorrow in Las Vegas, running through the 18th.
Voice 1: That's a lot of the vendor pitches we've covered this week about to get one big stage.
Voice 2: And the Houston Methodist staffing question is exactly the one most of those vendors will have to answer out loud.
Voice 1: Sources and corrections are at physicianintheloop.org, where you can sign up for the free email briefing. This briefing was read by AI voices.